Karolinska Institutet

Arne Östman received his PhD in 1990. Following a position as Group Leader at the Ludwig Institute for Cancer Research in Uppsala, Sweden he moved in 2004 to Karolinska Institutet, Stockholm, Sweden, where he was appointed Professor of Molecular Oncology in 2006. He is also visiting professor at CCBIO; University of Bergen, Bergen, Norway since 2015.

His major research interests are PDGF receptors as cancer drug targets and the roles of cancer-associated fibroblasts and pericytes in tumor growth, progression and drug response. He has published more than 160 research and review articles. Since 2006 he is coordinator of "STARGET", a research network focusing on translational of tumor stroma, supported by a 10-year research grant from the Swedish Research Council. In 2010 Östman was appointed co-director for the strategic cancer research program in cancer, STRATCAN, at Karolinska Institutet.

He has acted on the SAB for ESMO annual meeting and for TAT meetings, and has also participated on international SABs for e.g. MedImmune, Novartis, and ImClone.